Variable | ESLB-producing Enterobacteriaceae infection | HR (95%CI) | P | |
---|---|---|---|---|
Yes | No | |||
Age | ||||
< 50 years | 2 (17%) | 0.5 (0.1–2.7) | 0.5 | |
≥ 50 years | 10 (83%) | 62 (60%) | ||
Sex | ||||
Male | 2 (17%) | 58 (56%) | 0.16 (0.03–0.75) | 0.02 |
Female | 10 (83%) | 46 (44%) | ||
Diabetes mellitus | ||||
Yes | 2 (17%) | 80 (77%) | 0.9 (1.6–5.7) | 0.9 |
No | 10 (83%) | 24 (23%) | ||
Prior transplantation | ||||
Yes | 3 (25%) | 86 (83%) | 5.8 (1.2–30) | 0.04 |
No | 9 (75%) | 18 (17%) | ||
Prophylaxis group | ||||
Cefazolin | 10 (83%) | 53 (51%) | 4.7 (1.1–22.6) | 0.05 |
Ertapenem | 2 (17%) | 51 (49%) | ||
Acute allograft rejection | ||||
Yes | 1 (8%) | 26 (25%) | 14.5 (1.3–162) | 0.03 |
No | 11 (92%) | 78 (75%) | ||
Post-transplant Haemodialysis | ||||
Yes | 3 (25%) | 26 (25%) | 0.3 (0.06–1.2) | 0.09 |
No | 9 (75%) | 78 (75%) | ||
Nephrostomy | ||||
Yes | 1 (8%) | 8 (8%) | 0.8 (1.3–0.1) | 0.8 |
No | 11 (92%) | 96 (92%) | ||
Reoperation | ||||
Yes | 3 (25%) | 11 (11%) | 2.6 (0.6–12) | 0.2 |
No | 9 (75%) | 93 (89%) |